XML 144 R100.htm IDEA: XBRL DOCUMENT v3.22.4
Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details) - EUR (€)
€ in Millions
Sep. 14, 2021
Sep. 28, 2020
Jan. 23, 2020
Translate Bio      
Disclosure of detailed information about business combination [line items]      
Other intangible assets € 396    
Deferred tax liabilities (93)    
Other current and non-current assets and liabilities 235    
Cash and cash equivalents 247    
Shire contingent consideration liability (see Note D.18.) (323)    
Net assets of Translate Bio 462    
Goodwill 2,118    
Purchase price € 2,580    
Principia      
Disclosure of detailed information about business combination [line items]      
Other intangible assets   € 2,534  
Deferred tax liabilities   (436)  
Other current and non-current assets and liabilities   (38)  
Cash and cash equivalents   186  
Net assets of Translate Bio   2,246  
Goodwill   912  
Purchase price   € 3,158  
Synthorx      
Disclosure of detailed information about business combination [line items]      
Other intangible assets     € 1,549
Deferred tax liabilities     (269)
Other current and non-current assets and liabilities     36
Net assets of Translate Bio     1,316
Goodwill     930
Purchase price     € 2,246